Pain Phenotyping of Rheumatic Diseases - An Observational Study

NCT ID
NCT07829497
Registry status
Not yet recruiting
Study type
Observational
Sponsor
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Conditions
Ankylosing Spondylarthritis, Arthritis, Lupus Erythematosus, Systemic, Lupus Vasculitis, Central Nervous System, Rheumatic Diseases, Rheumatoid Arthritis, Sjogren's Syndrome, Spondylarthritis

Overview

ClinicalTrials.gov lists this study as Not yet recruiting.

Enrollment: 225 participants (Estimated).

What is being studied

  • Device: Bedside quantitative sensory testing

Who may be eligible

Ages
9 Years to 85 Years
Sex
All
Healthy volunteers accepted
No

ClinicalTrials.gov lists the following eligibility criteria.

* INCLUSION CRITERIA Inclusion Criteria for Subjects Suspected or Diagnosed with Rheumatic Diseases In order to be eligible to participate in this study, an individual must meet all of the following criteria: 1. Stated willingness to comply with all study procedures and availability for the duration of the study 2. Aged 9-85 years 3. Diagnosed or suspected of having a rheumatic disease. 4. Ability of the subject to understand and the willingness to sign a written informed consent document or assent. 5. Must be enrolled in one of the NIAMS protocols (01-AR-0227, 94-AR-0066, 11-AR-0223) 6. To be able to answer PRO questionnaires in either English and/or Spanish languages. Inclusion Criteria Healthy Volunteers 1. Stated willingness to comply with all study procedures and availability for the duration of the study 2. Aged 9-85 years 3. No known history of a rheumatic disease or any other chronic medical illness. 4. Ability of the subject to understand and the willingness to sign a written informed consent document or assent. 5. To be enrolled in either of the ongoing NIAMS protocols 01-AR-0227, 94-AR-0066, or 11-AR-0223. 6. To be able to answer PRO questionnaires in either English and/or Spanish languages. EXCLUSION CRITERIA An individual who meets any of the following criteria will be excluded from participation in this study: 1. Treatment with investigational drug or other investigational intervention while enrolled in this study. 2. Any physical exam finding that precludes bedside QST. 3. Developmental delay or cognitive impairment that interfere with following or understanding the test instructions. 4. Subjects using illicit or street drugs will be excluded. Subjects taking prescribed pain medications will not be excluded. 5. Any chronic medical condition that may hinder participation in the study as determined by the study PI.

Study locations

1 study location is listed.

Site recruitment status is not specified in the registry data for these locations.

Countries: United States

  • Maryland, United States: 1

Sample of listed locations

  • National Institutes of Health Clinical Center — Bethesda, Maryland, 20892, United States — Site recruitment status not specified in the registry data

Study details

Start date
October 6, 2026
Primary completion date
June 15, 2033
Completion date
June 15, 2036
First posted
September 21, 2026

Source and update information

Source
ClinicalTrials.gov
NCT ID
NCT07829497
Registry last updated
October 1, 2026
QualifiedStudies registry data refreshed
October 2, 2026
QualifiedStudies record fetched
October 2, 2026

View NCT07829497 on ClinicalTrials.gov

Trial information can change. Confirm current study details with the study team or the registry.

About joining clinical research

Find clinical trials you may match with

QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.

Find clinical trials you may match with | Clinical trial FAQ